Our study supplements a prior retrospective study which compared 10 persons who received TDF + 3TC as part of their initial regimen with 20 3TC-experienced persons who received TDF add-on; in that study, a greater proportion of persons initially receiving combination therapy achieved HBV DNA <2000 copies/mL (80% versus 55%) at one year of followup, although the result did not reach statistical significance [ 41 ].
← all excerpts
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients.
1
—
—